Telesis Bio and Cellibre Announce Collaboration to Optimize Development of Future BioXp® DBC instrument
October 19, 2022 09:00 ET
|
Telesis Bio
SAN DIEGO, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, and Cellibre, a leading manufacturing technology company,...